Articles by Veronica Miller

1 2 3 4 5

Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets

Assoumou, Lambert; Cozzi-Lepri, Alessandro; Brun-Vézinet, Françoise; More

AIDS. 24(3):365-371, January 28th, 2010.

Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy

Greub, Gilbert; Cozzi-Lepri, Alessandro; Ledergerber, Bruno; More

AIDS. 16(14):1967-1969, September 27th, 2002.

Durability of HIV-1 viral suppression over 3.3 years with multi-drug antiretroviral therapy in previously drug-naive individuals

Phillips, Andrew N.; Miller, Veronica; Sabin, Caroline; More

AIDS. 15(18):2379-2384, December 7th, 2001.

Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir

Kirk, Ole; Mocroft, Amanda; Pradier, Christian; More

AIDS. 15(8):999-1008, May 25th, 2001.

The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study

Mocroft, Amanda; Phillips, Andrew N.; Miller, Veronica; More

AIDS. 15(2):201-209, January 26th, 2001.

The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4–8 viral load

Lepri, Alessandro Cozzi; Miller, Veronica; Phillips, Andrew N.; More

AIDS. 15(1):47-54, January 5th, 2001.

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

Miller, Veronica; Sabin, Caroline; Hertogs, Kurt; More

AIDS. 14(18):2857-2867, December 22nd, 2000.

The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load

Miller, Veronica; Sabin, Caroline A.; Phillips, Andrew N.; More

AIDS. 14(14):2129-2136, September 29th, 2000.

Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples

Hertogs, Kurt; Bloor, Stuart; Kemp, Sharon D.; More

AIDS. 14(9):1203-1210, June 16th, 2000.

HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy

Miller, Veronica; Ait-Khaled, Mounir; Stone, Chris; More

AIDS. 14(2):163-171, January 28th, 2000.

Regional survival differences across Europe In HIV-positive people: the EuroSIDA study

Chiesi, Antonio; Mocroft, Amanda; Dally, Len G.; More

AIDS. 13(16):2281-2288, November 12th, 1999.

The M184 V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors

Miller, Veronica; Stürmer, Martin; Staszewski, Schlomo; More

AIDS. 12(7):705-712, May 7th, 1998.

Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and zidovudine in HIV-1-infected patients

Staszewski, Schlomo; Miller, Veronica; Rehmet, Sibylle; More

AIDS. 10(5):F1-F7, May 1996.

1 2 3 4 5